1600. Closing the gap on moxifloxacin breakpoints for Stenotrophomonas maltophilia

BACKGROUND: Moxifloxacin (MOX) has in vitro activity against Enterobacterales and Stenotrophomonas maltophilia (SM). Although MOX commonly displays lower minimum inhibitory concentration (MIC)(50/90) values against SM when compared to levofloxacin, there are currently no established MOX breakpoints...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Stone, Tyler J, Summers, Kate, Williamson, John, Palavecino, Elizabeth
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Poster Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776320/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1780
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items